Answer:
- Type 1 diabetes: the pancreas produces a hormone called insulin, which is responsible for regulating the bloodstream's sugar, helping it enter the cells to produce energy. When the pancreas does not produce it, type 1 diabetes occurs; It usually appears at an early age of life.
- Type 2 diabetes or diabetes mellitus: Is this type of diabetes insulin is insufficient or there is an organism resistance to it; It is the most common diabetes in adults.
- Hyperglycemia: Normal circulating sugar values and according to the method used to calculate its percentage range between 70 and 100 mg%. when we find values above 100 mg% it refers to hyperglycemia
- Hypoglycemia: when the normal circulating sugar values are below 70 mg%, it refers to hypoglycemia.
When explaining the status of a newborn who has persistent pulmonary hypertension to the parents, the nurse would integrate knowledge about the foramen ovale which is still open.
Pulmonary hypertension happens when the blood pressure in the arteries that connect the heart and lungs is too high. Lung blood vessels develop more muscle on their inner walls as a result of pulmonary hypertension.
Blood arteries in the lungs are constricted, obstructed, or damaged in pulmonary arterial hypertension (PAH), one kind of pulmonary hypertension.
Due to the injury, blood pressure in the arteries of the lungs increases and blood flow through the lungs is slowed.
During foetal development, blood can travel through the foramen ovale, a muscle opening between the left and right atriums, and skip the pulmonary circulation.
Hence, The nurse would provide information regarding the still-open foramen ovale when describing the condition of a newborn with persistent pulmonary hypertension to the parents.
Learn more about Pulmonary Hypertension here brainly.com/question/12974924
#SPJ4
Heart rate is controlled by the two branches of the autonomic nervous system
Answer:
With chemicals and atoms.
Explanation:
Atoms gooood and chemicals the good kind (medicine).
The first comparison of PROs with axi-cel, an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, to SOC as second-line treatment (Tx) in relapsed/refractory (R/R) LBCL in the pivotal Phase 3 ZUMA-7 project.
According to ZUMA-7, the first randomized, international, multicenter Phase 3 study comparing axi-cel to SOC in second-line R/R LBCL, axi-cel treatment results in a clinically significant improvement in QoL at D100 when compared to SOC as determined by many recognized PRO tools. In the SOC arm, in particular, score comparisons at later timepoints call for cautious interpretation because attrition brought on by EFS events may have selected participants with the greatest results. The statistics also point to a quicker return to pretreatment quality of life with axi-cel than with SOC. Treatment options for second-line R/R LBCL should be influenced by axi-better cel's clinical results and patient experience compared to SOC.
Learn more about ZUMA-7 here:-
brainly.com/question/23849777
#SPJ4
